Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience

被引:0
|
作者
Abreu, Andres A. [1 ]
Farah, Emile [1 ]
Coble, Collin [2 ]
Rail, Benjamin [1 ]
Alterio, Rodrigo E. [1 ]
Sridhar, Shweta [2 ]
Ogbevire, Yoma [2 ]
Nix, Robert [2 ]
Ngo, Fallon [2 ]
Wadwah, Anupama [3 ]
Augustine, Mathew M. [2 ]
Wang, Sam C. [4 ]
Karagkounis, Georgios [5 ]
Yopp, Adam [6 ]
Zeh, Herbert J. [6 ]
Polanco, Patricio M. [6 ]
机构
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] UTSW, Dallas, TX USA
[3] UTSW, Anesthesiol, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[5] Univ Texas Southwestern, Dallas, TX USA
[6] UT Southwestern Med Ctr, Dept Surg, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
72
引用
收藏
页码:S44 / S44
页数:1
相关论文
共 50 条
  • [41] The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany
    Reese, Mikko
    Eichelmann, Ann-Kathrin
    Nowacki, Tobias M.
    Pascher, Andreas
    Sporn, Judith C.
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01) : 113
  • [42] Morbidity and Mortality after Cytoreductive Surgery and HIPEC in a National Reference Center: A Six-Year Experience under Independent Evaluation
    Vilchez, Miguel Enrique Alberto
    Halskov, Sebastian
    Winter, Axel
    Pratschke, Johann
    Rau, Beate
    Guel, Safak
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [43] CYTOREDUCTIVE SURGERY (CRS) AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR PERITONEAL MALIGNANT TUMORS IN CHILDREN: INITIAL EXPERIENCE IN A SINGLE INSTITUTION
    Zhu, Zhiyun
    Wang, Huanmin
    Chang, Xiaofeng
    Meng, Deguang
    Wang, Jiarong
    Yang, Shen
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S63 - S63
  • [44] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Asian Patients: A 10-year Experience in a Single Institution
    Tan, G.
    Teo, M.
    Chan, W.
    Soo, K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S135 - S136
  • [45] Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience
    Arjona-Sanchez, A.
    Rufian-Pena, S.
    Sanchez-Hidalgo, J. M.
    Casado-Adam, A.
    Cosano-Alvarez, A.
    Briceno-Delgado, J.
    WORLD JOURNAL OF SURGERY, 2018, 42 (10) : 3120 - 3124
  • [46] Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience
    A. Arjona-Sanchez
    S. Rufian-Peña
    J. M. Sanchez-Hidalgo
    A. Casado-Adam
    A. Cosano-Alvarez
    J. Briceño-Delgado
    World Journal of Surgery, 2018, 42 : 3120 - 3124
  • [47] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian Cancer - An Asian Experience
    Chia, C. S.
    Tan, G.
    Tham, C.
    Soo, K.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S111 - S111
  • [48] Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative
    Nick C. Levinsky
    Mackenzie C. Morris
    Koffi Wima
    Jeffrey J. Sussman
    Syed A. Ahmad
    Jordan M. Cloyd
    Charles Kimbrough
    Keith Fournier
    Andrew Lee
    Sean Dineen
    Sophie Dessureault
    Jula Veerapong
    Joel M. Baumgartner
    Callisia Clarke
    Mohammad Y. Zaidi
    Charles A. Staley
    Shishir K. Maithel
    Jennifer Leiting
    Travis Grotz
    Laura Lambert
    Ryan J. Hendrix
    Sean Ronnekleiv-Kelly
    Courtney Pokrzywa
    Mustafa Raoof
    Oliver S. Eng
    Fabian M. Johnston
    Jonathan Greer
    Sameer H. Patel
    Journal of Gastrointestinal Surgery, 2020, 24 : 155 - 164
  • [49] Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Acs, Miklos
    Gerken, Michael
    Gajic, Ivana
    Mayr, Max
    Zustin, Jozef
    Piso, Pompiliu
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (07) : 3057 - 3067
  • [50] Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Miklos Acs
    Michael Gerken
    Ivana Gajic
    Max Mayr
    Jozef Zustin
    Pompiliu Piso
    Langenbeck's Archives of Surgery, 2022, 407 : 3057 - 3067